A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the phenotypic expression of these diseases.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• Interstitial lung disease
Locations
United States
Illinois
University of Chicago
RECRUITING
Chicago
Contact Information
Primary
Vanita Patel, MPH
773-702-1012
Time Frame
Start Date: 2005-09
Estimated Completion Date: 2030-12
Participants
Target number of participants: 4000
Authors
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID), Idiopathic Pulmonary Fibrosis Clinical Research Network
Leads: University of Chicago